Delivery Order SPE2DR25D1017-SPE2DR26F9BCN
- Not listed
- The Defense Logistics Agency awarded a $3,164.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). The contract is non-set-aside and competitively awarded, with an ultimate completion date of November 12, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.31 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed-price, competitively awarded contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The vaccine will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,608.20 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL) with completion scheduled for November 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,060.99 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price contract was issued on November 5, 2025, with an ultimate completion date of November 6, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major hub for pharmaceutical distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.60 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed price contract was competitively awarded without set-aside provisions and is scheduled for completion by August 28, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,816.22 for Boostrix TDAP vaccine in 0.5ML syringe format, with an ultimate completion date of June 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls within AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,372.94 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, classified as firm fixed price with no set-aside designation, was awarded on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $1,330.50 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes with a ceiling value of $35,977.31. This firm fixed price contract, with an ultimate completion date of December 9, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award utilized competitive...
- The Defense Logistics Agency awarded a $5,066.71 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract issued...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BCNDelivery Order
The Defense Logistics Agency awarded a $1,405.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This contract, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a small-value transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The delivery order is unclassified as a set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award falls within AmerisourceBergen's established role as a critical pharmaceutical vendor supporting federal medical supply chains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a comprehensive contract portfolio with the Defense Logistics Agency covering vaccines, medications, and medical supplies across multiple therapeutic domains. The parent SPE2DX indefinite delivery contract, valued at $999,999,999.00 through December 2026, serves as the overarching vehicle enabling the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. This delivery order for TDAP vaccine represents routine replenishment of critical immunization supplies needed by the Defense Health Agency and other federal healthcare systems. The contract was competitively awarded with no set-aside provisions, consistent with AmerisourceBergen's demonstrated capability to meet federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/8/25 |